OPA-15406 ointment (Difamilast, Otsuka Pharmaceutical Co., Ltd., Tokyo, Japan), a PDE4 inhibitor, ameliorated AD symptoms, including itch, in pediatric and adult AD patients [54,55,56]. This evidence concerns the gene PDE4A and Alzheimer disease.